X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation

被引:69
作者
Tubman, Venee N.
Levine, Jason E.
Campagna, Dean R.
Monahan-Earley, Rita
Dvorak, Ann M.
Neufeld, Ellis J.
Fleming, Mark D.
机构
[1] Childrens Hosp, Dana Farber Canc Inst, Div Hematol Oncol, Boston, MA 02115 USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[3] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Beth Israel Med Ctr, Dept Pathol, Boston, MA USA
关键词
D O I
10.1182/blood-2006-02-004101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We identified a family with gray platelet syndrome (GPS) segregating as a sex-inked trait. Affected males had a mild bleeding disorder, thrombocytopenia, and large agranular platelets characteristic of GPS, while obligate carrier females were asymptomatic but had dimorphic platelets on peripheral smear. Associated findings included mild erythrocyte abnormalities in affected males. Linkage analysis revealed a 63 cM region on the X chromosome between markers G10578 and DXS6797, which segregated with the platelet phenotype and included the GATA1 gene. Sequencing of GATA1 revealed a G-to-A mutation at position 759 corresponding to amino acid change Arg216Gln. This mutation was previously described as a cause of X-linked thrombocytopenia with thalassemia (XLTT) but not of gray platelet syndrome. Our findings suggest that XLTT is within a spectrum of disorders constituting the gray platelet syndrome, and we propose that GATA1 is an upstream regulator of the genes required for platelet ci-granule biogenesis.
引用
收藏
页码:3297 / 3299
页数:3
相关论文
共 17 条
[1]   Disease-causing mutations in the human genome [J].
Antonarakis, SE ;
Krawczak, M ;
Cooper, DN .
EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (Suppl 3) :S173-S178
[2]   Effects of the R216Q mutation of GATA-I on erythropoiesis and megakaryocytopoiesis [J].
Balduini, CL ;
Pecci, A ;
Loffredo, G ;
Izzo, P ;
Noris, P ;
Grosso, M ;
Bergamaschi, G ;
Rosti, V ;
Magrini, U ;
Ceresa, IF ;
Conti, V ;
Poggi, V ;
Savoia, A .
THROMBOSIS AND HAEMOSTASIS, 2004, 91 (01) :129-140
[3]   THE CPG DINUCLEOTIDE AND HUMAN GENETIC-DISEASE [J].
COOPER, DN ;
YOUSSOUFIAN, H .
HUMAN GENETICS, 1988, 78 (02) :151-155
[4]  
DVORAK AM, 1995, DIAGNOSTIC ULTRASTRU, V3
[5]   A new genetic isolate of gray platelet syndrome (GPS): Clinical, cellular, and hematologic characteristics [J].
Falik-Zaccai, TC ;
Anikster, Y ;
Rivera, CE ;
Horne, MK ;
Schliamser, L ;
Phornphutkul, C ;
Attias, D ;
Hyman, T ;
White, JG ;
Gahl, WA .
MOLECULAR GENETICS AND METABOLISM, 2001, 74 (03) :303-313
[6]   Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation [J].
Freson, K ;
Matthijs, G ;
Thys, C ;
Mariën, P ;
Hoylaerts, MF ;
Vermylen, J ;
Van Geet, C .
HUMAN MOLECULAR GENETICS, 2002, 11 (02) :147-152
[7]   Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation [J].
Freson, K ;
Devriendt, K ;
Matthijs, G ;
Van Hoof, A ;
De Vos, R ;
Thys, C ;
Minner, K ;
Hoylaerts, MF ;
Vermylen, J ;
Van Geet, C .
BLOOD, 2001, 98 (01) :85-92
[8]   Selective impairment of platelet activation to collagen in the absence of GATA1 [J].
Hughan, SC ;
Senis, Y ;
Best, D ;
Thomas, A ;
Frampton, J ;
Vyas, P ;
Watson, SP .
BLOOD, 2005, 105 (11) :4369-4376
[9]   X-linked thrombocytopenia caused by a novel mutation of GATA-1 [J].
Mehaffey, MG ;
Newton, AL ;
Gandhi, MJ ;
Crossley, M ;
Drachman, JG .
BLOOD, 2001, 98 (09) :2681-2688
[10]   ELECTRON-MICROSCOPIC AND FUNCTIONAL-STUDIES ON PLATELETS IN GRAY PLATELET SYNDROME [J].
MORI, K ;
SUZUKI, S ;
SUGAI, K .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 143 (03) :261-287